APOBEC3A and cancer: Indeed, the extended sequence context in which SBS2 and SBS13 mutations occur in human cancers is predominantly that at which APOBEC3A, rather than APOBEC3B, induces mutations in yeast (TCN preceded by a pyrimidine base rather than a purine) (Chan et al., 2015).